Tilray Earnings Review | 
		
| November 14, 2018 | November 2018 Bond Updates | 
|  
					Tilray Inc. fell over 5% after hours after the Canadian pharmaceutical and cannabis company reported earnings. Tilray lost 20 cents last quarter which missed the Street's estimate for a 14 cent loss.  | 
		
| View more at: https://www.forbes.com/sites/adamsarhan/2018/11/13/tilray-earnings-review/ | 
| Related News | 
										
						
 
 
 
  |